institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Rakuten Medical Selected to Participate in FDA CEO Forum in San Diego

  • Rakuten Medical, Inc. was selected by the U.S. Food and Drug Administration to participate in the FDA CEO Forum in San Diego on June 13, 2025.
  • Minami Maeda represented Rakuten Medical at the panel to discuss modernization of the regulatory framework with FDA Commissioner Marty A. Makary.
  • Rakuten Medical's Alluminox platform has the potential to transform cancer therapy in the U.S.
  • The company is conducting a global Phase 3 clinical trial for its ASP-1929 photoimmunotherapy treatment for head and neck squamous cell carcinoma.
Insights by Ground AI
Does this summary seem wrong?

32 Articles

All
Left
2
Center
13
Right
Aspen Daily NewsAspen Daily News
+31 Reposted by 31 other sources
Center

Rakuten Medical Selected to Participate in FDA CEO Forum in San Diego

Engaged with FDA Commissioner on shared commitment to fast, safe, and affordable patient access to innovative therapies

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 87% of the sources are Center
87% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Billings Gazette broke the news in Billings, United States on Friday, June 13, 2025.
Sources are mostly out of (0)

Similar News Topics